Ichthyosis: Clinical Trials

2 trials for Ichthyosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2
Phase 32Terminated 2

Follow Ichthyosis: new trials by email Literature Review of Ichthyosis trials Research Report on Ichthyosis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome
Spesolimab - solution for infusion, Placebo matching to spesolimab - solution for infusion, Spesolimab - solution for injection - Netherton Syndrome
Phase 2 / Phase 3TerminatedBoehringer Ingelheim432023-06-122026-03-12
A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome
Dupilumab Prefilled Syringe, Placebo Prefilled Syringe - Netherton Syndrome
Phase 2 / Phase 3TerminatedUniversity Hospital, Toulouse102020-07-232026-09-21

Narrower conditions

Netherton Syndrome (2)

Broader conditions

Abnormalities, Multiple (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Genetic Diseases, Inborn (2)  ·  Ichthyosiform Erythroderma, Congenital (2)  ·  Infant, Newborn, Diseases (2)  ·  Keratosis (2)  ·  Skin Abnormalities (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Injections (1)  ·  spesolimab (1)

Sponsors

Boehringer Ingelheim (1)  ·  University Hospital, Toulouse (1)

Countries

France (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  China (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Japan (1)  ·  Malaysia (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)